These findings suggest that our HDM model does not fully recapitulate a type 2-driven asthma phenotype but instead reflects non-type 2 asthma, often characterized by inflammasome activation, interferon signaling and IL-17 pathways (Liu et al., 2024). This evidence concerns the gene IL17A and asthma.